IL1B and congenital rubella syndrome: In conclusion, our study demonstrated that among the cytokines produced by engaged CAR-T cells per se and myeloid cells activated by CAR-T therapy, TNFα and IL1β were the main mediators of vascular endothelial activation, which are potential targets of cytokine therapy for CAR-T-associated CRS and neurotoxicity.